Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A conjugate of an oligosaccharide fragment of tumor-associated ganglioside antigen with hemocyanin is a prototype antitumor vaccine.

× No keyword cloud information.

11 in total

1. Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.

Authors: P B Chapman; D M Morrissey; K S Panageas; W B Hamilton; C Zhan; A N Destro; L Williams; R J Israel; P O Livingston
Journal: Clin Cancer Res Date: 2000-03 Impact factor: 12.531

Review 2. Design of peptide-based vaccines for cancer.

Authors: G A Pietersz; D S Pouniotis; V Apostolopoulos
Journal: Curr Med Chem Date: 2006 Impact factor: 4.530

3. Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer.

Authors: Dirk Nagorsen; Eckhard Thiel
Journal: Clin Cancer Res Date: 2006-05-15 Impact factor: 12.531

4. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides.

Authors: M Kotani; H Ozawa; I Kawashima; S Ando; T Tai
Journal: Biochim Biophys Acta Date: 1992-07-21

5. Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity.

Authors: Marcelo D Guthmann; Roberto J Bitton; Ariel J L Carnero; Mariano R Gabri; Gabriela Cinat; Leonardo Koliren; Daniel Lewi; Luis Enrique Fernandez; Daniel F Alonso; Daniel E Gómez; Leonardo Fainboim
Journal: J Immunother Date: 2004 Nov-Dec Impact factor: 4.456

Review 6. Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

Authors: Giorgio Parmiani; Chiara Castelli; Piero Dalerba; Roberta Mortarini; Licia Rivoltini; Francesco M Marincola; Andrea Anichini
Journal: J Natl Cancer Inst Date: 2002-06-05 Impact factor: 13.506

7. The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein.

Authors: Therese Buskas; Yanhong Li; Geert-Jan Boons
Journal: Chemistry Date: 2004-07-19 Impact factor: 5.236

A conjugate of an oligosaccharide fragment of tumor-associated ganglioside antigen with hemocyanin is a prototype antitumor vaccine.